MapLight Therapeutics, Inc. — All Filings
92 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
3/A
4
424B3
8-A12B
8-K
CERT
D
D/A
DRS
DRS/A
FWP
S-1
S-1/A
S-8
SCHEDULE 13D
SCHEDULE 13G
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| S-8 | S-8 | 0001193125-26-125105 | Mar 26, 2026 | — |
| 10-K | 10-K | 0001193125-26-125072 | Mar 26, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-26-125062 | Mar 26, 2026 | — |
| 4 | — | 0002021198-26-000011 | Feb 24, 2026 | Feb 20, 2026 |
| 144 | — | 0001950047-26-001737 | Feb 24, 2026 | — |
| 144 | — | 0001950047-26-001664 | Feb 23, 2026 | — |
| 4 | — | 0001470798-26-000002 | Feb 20, 2026 | Feb 18, 2026 |
| 144 | — | 0001950047-26-001564 | Feb 20, 2026 | — |
| 4 | — | 0002021198-26-000009 | Feb 18, 2026 | Feb 13, 2026 |
| SCHEDULE 13G | — | 0001897612-26-000296 | Feb 17, 2026 | — |
| SCHEDULE 13G | — | 0001193125-26-053187 | Feb 17, 2026 | — |
| 144 | — | 0001950047-26-001246 | Feb 13, 2026 | — |
| 4 | — | 0001998937-26-000002 | Feb 12, 2026 | Feb 10, 2026 |
| 4 | — | 0002021198-26-000007 | Feb 12, 2026 | Feb 10, 2026 |
| 144 | — | 0001950047-26-001147 | Feb 11, 2026 | — |
| 144 | — | 0001950047-26-001098 | Feb 10, 2026 | — |
| 4 | — | 0001709954-26-000004 | Feb 9, 2026 | Feb 5, 2026 |
| 4 | — | 0002021256-26-000004 | Feb 9, 2026 | Feb 5, 2026 |
| 4 | — | 0001728746-26-000004 | Feb 9, 2026 | Feb 5, 2026 |
| 4 | — | 0002021238-26-000004 | Feb 9, 2026 | Feb 5, 2026 |
| 4 | — | 0001789970-26-000004 | Feb 9, 2026 | Feb 5, 2026 |
| 4 | — | 0002021233-26-000004 | Feb 9, 2026 | Feb 5, 2026 |
| 4 | — | 0001658918-26-000004 | Feb 9, 2026 | Feb 5, 2026 |
| 4 | — | 0002021198-26-000005 | Feb 4, 2026 | Feb 2, 2026 |
| 144 | — | 0001950047-26-000881 | Feb 3, 2026 | — |
| 144 | — | 0001950047-26-000840 | Feb 2, 2026 | — |
| 4 | — | 0002021198-26-000003 | Jan 30, 2026 | Jan 28, 2026 |
| 144 | — | 0001950047-26-000766 | Jan 30, 2026 | — |
| 4 | — | 0002021256-26-000002 | Jan 29, 2026 | Jan 27, 2026 |
| 4 | — | 0001728746-26-000002 | Jan 29, 2026 | Jan 27, 2026 |
| 4 | — | 0002021238-26-000002 | Jan 29, 2026 | Jan 27, 2026 |
| 4 | — | 0001709954-26-000002 | Jan 29, 2026 | Jan 27, 2026 |
| 4 | — | 0001658918-26-000002 | Jan 29, 2026 | Jan 27, 2026 |
| 4 | — | 0002021233-26-000002 | Jan 29, 2026 | Jan 27, 2026 |
| 4 | — | 0001789970-26-000002 | Jan 29, 2026 | Jan 27, 2026 |
| 144 | — | 0001950047-26-000748 | Jan 29, 2026 | — |
| 144 | — | 0001950047-26-000728 | Jan 28, 2026 | — |
| 8-K | 8-K | 0001193125-26-008267 | Jan 9, 2026 | — |
| 10-Q | 10-Q | 0001193125-25-307453 | Dec 4, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-307450 | Dec 4, 2025 | — |
| SCHEDULE 13D | — | 0001104659-25-114697 | Nov 20, 2025 | — |
| 3/A | — | 0001470798-25-000008 | Nov 18, 2025 | Oct 25, 2025 |
| SCHEDULE 13D | — | 0001388325-25-000021 | Nov 4, 2025 | — |
| 4 | — | 0001388325-25-000018 | Oct 30, 2025 | Oct 28, 2025 |
| 4 | — | 0001900201-25-000008 | Oct 29, 2025 | Oct 28, 2025 |
| 8-K | 8-K | 0001193125-25-255041 | Oct 29, 2025 | Oct 26, 2025 |
| 4 | — | 0001998937-25-000006 | Oct 28, 2025 | Oct 27, 2025 |
| 4 | — | 0001826519-25-000008 | Oct 28, 2025 | Oct 27, 2025 |
| 4 | — | 0001789970-25-000008 | Oct 28, 2025 | Oct 27, 2025 |
| 4 | — | 0001709954-25-000007 | Oct 28, 2025 | Oct 27, 2025 |